ASMS: Bruker eXceed Symposia - Multiomics solutions for the post-genomic era

eXceed Symposia - Multiomics solutions for the post-genomic era at ASMS 2024

• June 2, 2024 8:30 am - 1:05 pm PST
• Westin Anaheim, 1030 West Katella Avenue, Anaheim, CA, USA

Register here!

Plenary session

Annabella Ballroom A-B

8:30 am Welcome and introduction

• Rohan A. Thakur, Ph.D., President, Life Sciences Mass Spectrometry Division, Bruker, Fällanden, Switzerland

8:50 am It is in our blood, protein-centric approaches to tackle your antibody repertoires

• Albert Heck, Ph.D., Professor, Chemistry and Pharmaceutical Sciences, Utrecht University and Scientific Director, Netherlands Proteomics Center, Utrecht, Netherlands

9:15 am From Blood to the Brain; how integrated spatial and LC-based data advance our understanding of neurodegenerative diseases

• Blaine R. Roberts, Ph.D., Associate Professor and Principal Investigator, Emory University School of Medicine, Atlanta, GA, USA

9:40 am Probing Cellular Heterogeneity via Spatially Resolved Omics and Mass Spectrometry Imaging

• Lingjun Li, Ph.D., Vilas Distinguished Achievement Professor, Charles Melbourne Johnson Distinguished Chair Professor, University of Wisconsin-Madison, WI, USA

10:05 am After the plenary session, the meeting will break into three parallel sessions.

Breakout Session Proteomics

Annabella Ballrooms A-B

10:30 am Introduction

• Daniel Hornburg, Ph.D., Vice President, Biomarkers and Precision Medicine, Bruker Scientific LLC, Billerica, MA, USA

10:45 am High throughput protein analysis of single cells and subcellular organelles reveals regulatory principles

• Nikolai Slavov, Ph.D., Director, Parallel Squared Technology Institute and Professor, Northeastern University, Boston, MA, USA

11:10 am Precision proteomics in human disease

• Roman Fischer, Ph.D., Associate Professor, University of Oxford, Centre for Medicines Discovery (CMD), Target Discovery Institute (TDI), CAMS Oxford Institute (COI), Oxford, UK

11:35 am Refreshments

12:00 pm Profiling oncogenic transcription factors using mass spectrometry proteomics

• Lindsay Pino, Ph.D., Co-Founder and CTO, Talus Bio, Seattle, WA, USA

12:25 pm Intra- and inter-cellular communication in 2D and 3D cell models of health and disease

• Ileana Cristea, Ph.D., Henry L. Hillman Professor of Molecular Biology, Princeton University, NJ, USA

12:50 pm End of meeting

Breakout Session MALDI Imaging/SpatialOMx®

Annabella Ballroom C-D

10:30 am Introduction

• Mike Easterling, Ph.D., VP Global Imaging, Bruker Scientific LLC, Billerica, MA, USA

10:35 am New instrumentation for biomedical SpatialOMx applications

• Carsten Hopf, Ph.D., Professor and Head of CeMOS, Mannheim - M2Aind Industry Consortium, Mannheim, Germany

10:55 am 120-plex MALDI-IHC recapitulates tissue structures and reveals diverse spatial features of endometrial cancer

• Mengze Stettler-Zhang, Graduate Student, University of Zurich and ETH Zurich, Zurich, Switzerland

11:15 am Integrated multi-omics approaches for the analysis of lung adenocarcinoma

• Brian Hoffman, Ph.D., Director, Mass Spectrometry Services and Protein Sciences, The Jackson Laboratory, Bar Harbor, ME, USA

11:35 am Refreshments

12:00 pm Single-Cell Omni-Omics (SC-OO): Analysis of Captured Single Cells by multi-modal MALDI-IMS

• Jake Dressman, Graduate Student, Medical University of South Carolina, Charleston, SC, USA

12:20 pm Unparalleled Spatial Multiomics at the Tissue and Single-Cell Level with MALDI HiPLEX-IHC

• Mark Lim, Ph.D., Executive VP and CSO, AmberGen, Waltham, MA, USA

12:40 pm Integration of Multiplexed Multi-omic Imaging for a Deeper Understanding of the Tumor Microenvironment

• Erin Seeley, Ph.D., Director, Mass Spectrometry Imaging Facility, University of Texas, Austin, TX, USA

13:00 pm End of meeting

Breakout Session Multiomics

Gloriana A-C

10:30 am Introduction

• Erica Forsberg, Ph.D., Vice President, Metabolomics, AMER and APAC, Bruker Scientific LLC, Billerica, MA, USA
• Matt Lewis, Ph.D., Vice President, Metabolomics, EMEA, Bruker UK Ltd., Coventry, UK
• Klaus Lindpaintner, Ph.D., Vice President, Glycobiology Solutions, Bruker Scientific LLC, Billerica, MA, USA

10:45 am Glycan database-free real-time analysis of dda-PASEF glycoproteomics data using GlycoScape software and the Myriad algorithm

• Hans Wessels, Ph.D., Proteomics Scientist, Radboud University, Nijmegen, Netherlands

11:10 am 4D-Lipidomics™ - enhanced deep lipidome coverage and profiling in clinical specimens

• Laura Bindila, Ph.D., Head of Clinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center Mainz, Germany

11:35 am Refreshments

12:00 pm Advances in Leveraging Unannotated Data and Machine Learning for Metabolite Structure Prediction

• David Healey, Vice President of Data Science and Machine Learning, Enveda Biosciences, Salt Lake City, USA

12:20 pm High throughput mass spectrometry for next-generation multi-omics biomarker discovery

• Mo Jain, Ph.D., Founder and CEO, Sapient, San Diego, CA, USA

12:40 pm 4D-Lipidomics™ in a Core Facility

• Kari Basso, Ph.D., Director of Mass Spectrometry Research and Education, University of Florida, Gainesville, FL, USA

13:05 pm End of Meeting